Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Pre Stabilisation Notice

1 Jul 2020 11:07

RNS Number : 7204R
HSBC Bank plc
01 July 2020
 

1st July 2020

 

B&M EUROPEAN VALUE RETAIL S.A. 

Pre Stabilisation Notice

HSBC (contact: 'synd manager'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

B&M EUROPEAN VALUE RETAIL S.A.

Guarantor (if any):

na

Aggregate nominal amount:

GBP 350,000,000

Description:

Fixed 2025NC2

Offer price:

TBC /

Other offer terms:

 

Stabilisation:

Stabilising Manager(s):

BNP Paribas, HSBC, Barclays, BoFA, Commerzbank, Goldman Sachs, Lloyds

Stabilisation period expected to start on:

3rd July 2020

Stabilisation period expected to end no later than:

12th August 2020

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

 In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAGZGGNGMDGGZM
Date   Source Headline
18th Jun 202610:00 amRNSBoard Retirement
18th Jun 202610:00 amRNSPublication of Annual Report and Notice of AGM
16th Jun 202612:00 pmRNSDirector/PDMR Shareholding
11th Jun 20261:00 pmRNSTiming of Q1 FY27 Trading Statement
3rd Jun 20267:00 amRNSFY26 Preliminary Results
10th Apr 20269:00 amRNSDirectorate Changes and Leadership Appointments
26th Mar 20264:45 pmRNSMajor Holding(s) in Company - TR1
24th Mar 20264:30 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:31 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:30 pmRNSMajor Holding(s) in Company - TR1
9th Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20268:00 amRNSAdmission of B&M Jersey Shares
2nd Mar 20268:00 amRNSReadmission - B&M European Value Retail S.A.
27th Feb 20264:48 pmRNSMigration Completion
25th Feb 202611:00 amRNSPublication of a Prospectus - Migration
24th Feb 20261:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:00 pmRNSUpdate statement on 2025 AGM voting results
22nd Jan 20267:00 amRNSQ3 FY26 Trading Statement
15th Jan 20269:00 amRNSBlock listing Interim Review
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
4th Dec 202510:00 amRNSMajor Holding in Company - TR1
28th Nov 202511:00 amRNSMajor Holding in Company - TR1
26th Nov 20259:30 amRNSMajor Holding in Company TR1
24th Nov 20252:30 pmRNSMajor Holding in Company- TR1
20th Nov 20254:00 pmRNSCEO Purchase of shares
20th Nov 202511:00 amRNSCEO Purchase of Shares
19th Nov 20259:01 amRNSCEO Purchase of Shares
19th Nov 20259:00 amRNSMajor Holding in Company TR1
18th Nov 202511:00 amRNSCEO Purchase of Shares
18th Nov 202510:58 amRNSMajor Holding in Company- TR1
14th Nov 20253:30 pmRNSMajor Holding in Company TR1
13th Nov 20257:00 amRNSFY26 Interim Results
4th Nov 20256:05 pmRNSMajor Holding in Company TR1
4th Nov 20256:00 pmRNSMajor Holding in Company TR1
30th Oct 20259:00 amRNSMajor Holding in Company TR1
28th Oct 20254:00 pmRNSMajor Holding in Company TR1
27th Oct 20251:01 pmRNSMajor Holding in Company TR1
27th Oct 20251:00 pmRNSMajor Holding in Company TR1
20th Oct 20257:00 amRNSUpdate on FY26 Guidance and Directorate Change
13th Oct 20253:30 pmRNSInformation to shareholders: statutory migration
7th Oct 20257:00 amRNSFY26 H1 Trading and Operational Update
22nd Sep 202511:30 amRNSCEO Purchase of Shares
18th Sep 20256:00 pmRNSDirector/PDMR Shareholding
15th Sep 20254:34 pmRNSCEO Purchase of Shares
11th Sep 202511:00 amRNSCEO Purchase of Shares
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20254:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.